HPRHealth Psychology ResearchTBA2420-8124Health Psychology Research10.52965/001c.120958GeneralExploring the Psychological Side of Fentanyl: A Scoping Review to   Disclose the Psychosocial Dimensions of Illicitly Manufactured   Fentanyl Usershttps://healthpr.org/journal/HPR/12/1/10.52965/001c.120958CaponnettoPasquale,TriscariSergio,PrezzaventoGraziella Chiara,FarrugioGiorgia,FarrautoChiara,LanzafameSimona,SchiliròGiulia,UccelliEleonora,VitaleNoemi Maria,FakhrouAbdulnaser,NagiKarim,ConcertoCarmen20241212024-09-21Background Fentanyl is a powerful opioid. The abuse and overdoses related to Illicitly Manufactured Fentanyl (IMF) have become more prevalent. The majority of clinical studies on fentanyl have focused on its medical and biological aspects, particularly its addictive properties. Few studies have delved into the psychological aspects of illicit fentanyl use, and there is currently no comprehensive review providing a structured psycho-social profile of the population groups most vulnerable to its effects. The goal of this Scoping Review was to construct a psychological and social profile of individuals at risk of using illicit fentanyl. This profile will serve as a guiding force for shaping behavioral policies and public health prevention efforts necessary to face the recent pandemic. Methods Following the PRISMA guidelines we conducted a Scoping Review focused on the following research question: What are the practical psycho-social implications of illicit fentanyl use in the global population? Results The bibliographic research was carried out in the databases of Medline, Scopus, and PsycNet. The articles resulting from the research phase in the databases listed above produced a total of 17737 reports. After the screening process, 10 studies were included in the scoping review. Discussion and Conclusion This scoping review was the first to consistently and systematically outline the psychosocial implications of fentanyl dependence. Users of IMF are consistently younger than other drug users. People using fentanyl have a relatively low perception of risk. On the psycho-social levels, there is a significant correlation between fentanyl use and mental disorders such as suicidal thoughts, anxiety disorders, and depression. The development of psychotherapy, along with digital tools such as apps and online platforms, can be an initial step in addressing this challenge.Fentanyl, Illicitly Manufactured Fentanyl, Fentanyl and Psychology, Fentanyl and Psychological Dependence, Clinical psychology

1. Kuczyńska K, Grzonkowski P, Kacprzak Ł, Zawilska JB. Abuse of fentanyl: An emerging problem to face. Forensic Sci Int. 2018;289:207-214. doi:10.1016/j.forsciint.2018.05.0422. Ni L et al. Evaluating Drug Interactions between Ritonavir and Opioid Analgesics: Implications from Physiologically Based Pharmacokinetic Simulation. Pharmaceuticals. 2024;17(5):640. doi:10.3390/ph170506403. Vardanyan RS, Hruby VJ. Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications. Future Med Chem. 2014;6(4):385-412. doi:10.4155/fmc.13.2154. Volpe DA, McMahon Tobin GA, Mellon RD, et al. Uniform assessment and ranking of opioid µ receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol. 2011;59(3):385-390. doi:10.1016/j.yrtph.2010.12.0075. Han Y, Cao L, Yuan K, Shi J, Yan W, Lu L. Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse. Neurosci Bull. 2022;38(11):1365-1382. doi:10.1007/s12264-022-00872-36. Comer SD, Cahill CM. Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neurosci Biobehav Rev. 2019;106:49-57. doi:10.1016/j.neubiorev.2018.12.0057. Gibney E, Petrić Howe N. Fentanyl addiction: the brain pathways behind the opioid crisis. Nature. Published online May 2024. doi:10.1038/d41586-024-01541-38. Giorgetti A, Centola C, Giorgetti R. Fentanyl novel derivative-related deaths. Hum Psychopharmacol. 2017;32(3). doi:10.1002/hup.26059. Han Y, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry. 2019;9(1):282. doi:10.1038/s41398-019-0625-010. World Health Organization. Opioid Overdose. https://www.who.int/news-room/fact-sheets/detail/opioid-overdose11. Chandra DK, Altice FL, Copenhaver MM, Zhou X, Didomizio E, Shrestha R. Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs. Subst Use Misuse. 2021;56(7):979-987. doi:10.1080/10826084.2021.190193112. D’Orazio J, Nelson L, Perrone J, Wightman R, Haroz R. Xylazine Adulteration of the Heroin–Fentanyl Drug Supply: A Narrative Review. Ann Intern Med. 2023;176(10):1370-1376. doi:10.7326/M23-200113. Reed MK, Imperato NS, Bowles JM, Salcedo VJ, Guth A, Rising KL. Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips. Drug Alcohol Depend Rep. 2022;30(4):100074. doi:10.1016/j.dadr.2022.10007414. Cárdenas-Quesada J, Torrens M, Farré M. Fentanyl and its derivatives, xylazine, and benzodiazepines: new sources of risk for acute poisonings. Emergencias. Published online May 2024. doi:10.55633/s3me/E036.202315. Hayashi K, Milloy MJ, Lysyshyn M, et al. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1-6. doi:10.1016/j.drugalcdep.2017.10.02016. Kenney SR, Anderson BJ, Conti MT, Bailey GL, Stein MD. Expected and actual fentanyl exposure among persons seeking opioid withdrawal management. J Subst Abuse Treat. 2018;86:65-69. doi:10.1016/j.jsat.2018.01.00517. Hochstatter KR et al. Characteristics and correlates of fentanyl preferences among people with opioid use disorder. Drug Alcohol Depend. 2022;240(17):109630. doi:10.1016/j.drugalcdep.2022.10963018. Solis E, Cameron-Burr KT, Shaham Y, Kiyatkin EA. Fentanyl-Induced Brain Hypoxia Triggers Brain Hyperglycemia and Biphasic Changes in Brain Temperature. Neuropsychopharmacology. 2018;43(4):810-819. doi:10.1038/npp.2017.18119. Tsang VWL et al. Systematic review on intentional non-medical fentanyl use among people who use drugs. Front Psychiatry. 2024;15:1347678. doi:10.3389/fpsyt.2024.134767820. Kranke P, Eberhart LH, Roewer N, Tramèr MR. Pharmacological Treatment of Postoperative Shivering: A Quantitative Systematic Review of Randomized Controlled Trials: Anesth Analg. 2002;94(2):453-460. doi:10.1097/00000539-200202000-0004321. Kim N, Park JH, Lee JS, Choi T, Kim M. Effects of intravenous fentanyl around the end of surgery on emergence agitation in children: Systematic review and meta-analysis. Pediatr Anesth. 2017;27(9):885-892. doi:10.1111/pan.1318122. Song L, Tan S, Chen Q, Li H. Effect of Fentanyl as an Adjuvant to Brachial Plexus Block for Upper Extremity Surgeries: A Systematic Review and Meta-Analysis of RCTs. Pain Res Manag. 2022;2022:1-13. doi:10.1155/2022/870456923. Tricco AC et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467-473. doi:10.7326/M18-085024. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi:10.1136/bmj.l489825. Higgins JPT, Morgan RL, Rooney AA, et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int. 2024;186:108602. doi:10.1016/j.envint.2024.10860226. Hong QN, Pluye P, Fàbregues S, et al. Improving the content validity of the mixed methods appraisal tool: a modified e-Delphi study. J Clin Epidemiol. 2019;111:49-59.e1. doi:10.1016/j.jclinepi.2019.03.00827. Souto RQ, Khanassov V, Hong QN, Bush PL, Vedel I, Pluye P. Systematic mixed studies reviews: updating results on the reliability and efficiency of the Mixed Methods Appraisal Tool. Int J Nurs Stud. 2015;52(1):500-501. doi:10.1016/j.ijnurstu.2014.08.01028. Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J Evid Based Healthc. 2015;13(3):179-187. doi:10.1097/XEB.000000000000006229. Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Drug Alcohol Depend. 2019;204:107547. doi:10.1016/j.drugalcdep.2019.10754730. Gunn CM et al. Age-based preferences for risk communication in the fentanyl era: 'A lot of people keep seeing other people die and that's not enough for them.’ Addiction. 2021;116(6):1495-1504. doi:10.1111/add.1530531. Kasson E et al. Using Social Media to Examine Themes Surrounding Fentanyl Misuse and Risk Indicators. Subst Use Misuse. 2023;58(7):920-929. doi:10.1080/10826084.2023.219657432. Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and Treatment of Opioid Misuse and Addiction: A Review. JAMA Psychiatry. 2019;76(2):208-216. doi:10.1001/jamapsychiatry.2018.312633. Brar R et al. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada. Am J Drug Alcohol Abuse. 2020;46(5):625-631. doi:10.1080/00952990.2020.177172134. McKnight C, Des Jarlais DC. Being ‘hooked up’ during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82-88. doi:10.1016/j.drugpo.2018.08.00435. Harris MTH et al. Competing risks of women and men who use fentanyl: ‘The number one thing I worry about would be my safety and number two would be overdose.’ J Subst Abuse Treat. 2021;125:108313. doi:10.1016/j.jsat.2021.10831336. Connery HS et al. Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder. Drug Alcohol Depend. 2019;205:107612. doi:10.1016/j.drugalcdep.2019.10761237. Macmadu A et al. Drug use behaviors, trauma, and emotional affect following the overdose of a social network member: A qualitative investigation. Int J Drug Policy. 2022;107:103792. doi:10.1016/j.drugpo.2022.10379238. He Y et al. Effectiveness of a Mindfulness Meditation App Based on an Electroencephalography-Based Brain-Computer Interface in Radiofrequency Catheter Ablation for Patients With Atrial Fibrillation: Pilot Randomized Controlled Trial. JMIR MHealth UHealth. 2023;11:e44855. doi:10.2196/4485539. Chudnofsky CR, Wright SW, Dronen SC, Borron SW, Wright MB. The safety of fentanyl use in the emergency department. Ann Emerg Med. 1989;18(6):635-639. doi:10.1016/S0196-0644(89)80517-7